The Claim
In 26% of men with pelvic lymph node metastases, 18F-PSMA-1007 PET/CT was the only imaging modality to detect metastases, while both whole-body MRI and CT reported negative findings, indicating that 18F-PSMA-1007 PET/CT can identify disease missed by standard imaging.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For about 1 in 4 men with cancer spread to the pelvic lymph nodes, a special PET scan called 18F-PSMA-1007 found the cancer when regular MRI and CT scans didn’t see anything — meaning this new scan might catch things others miss.
See the scientific wording
In 26% of men with pelvic lymph node metastases, 18F-PSMA-1007 PET/CT was the only imaging modality to detect metastases, while both whole-body MRI and CT reported negative findings, indicating that 18F-PSMA-1007 PET/CT can identify disease missed by standard imaging.
What the research says
1 studyThis study found that in about 1 in 4 men with prostate cancer spread to lymph nodes, a special scan called 18F-PSMA-1007 PET/CT could see the cancer when regular MRI and CT scans missed it — meaning this new scan is better at finding hidden spread.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.